Begin typing your search above and press return to search.
Buds and brains
access_time 21 Jun 2024 6:34 AM GMT
Is Europe leaning to the right?
access_time 20 Jun 2024 6:28 AM GMT
Rumors about the Floating Port !
access_time 19 Jun 2024 5:45 AM GMT
Homechevron_rightIndiachevron_rightMaharashtra cancels...

Maharashtra cancels license of Johnson & Johnson baby powder over quality concerns

Maharashtra cancels license of Johnson & Johnson baby powder over quality concerns

Mumbai: The Maharashtra Government has canceled Johnson and Johnson's product manufacturing license of Johnson's Baby Powder in the state. The Maharashtra FDA issued a press note notifying that Johnson & Johnson's will not be able to manufacture or sell the talc-based baby powder in Maharashtra after it was found that the product has a pH value above the mandated limit.

In the release issued on Friday, the state government agency said the company's product, Johnson's Baby Powder, may affect the skin of newborn babies.

Samples of the powder for babies did not conform to standard pH value during a laboratory test, the regulator said in its statement, reported Press Trust of India.

The release said the action was taken after Kolkata-based Central Drugs Laboratory's conclusive report that concludes "the sample does not conform to IS 5339:2004 with respect to the test for pH."

According to the release, FDA had drawn samples of Johnson's Baby Powder from Pune and Nashik for quality check purposes, reported Press Trust of India.

The government analyst had declared the samples as "not of the standard quality" as they do not comply with IS 5339:2004 specification for skin powder for infants in the test pH, it said.

Thereafter, FDA issued a show-cause notice to Johnson and Johnson under the Drugs Cosmetics Act 1940 and Rules, besides issuing instructions to the company to recall the stock of the said product from the market, said the release.

The firm "didn't accept the report" of the government analyst and challenged it in court for sending it to the Central Drugs Laboratory, it added.

A detailed statement from Johnson & Johnson Pvt Ltd is awaited.

Show Full Article
TAGS:MaharashtraJohnson& Johnson
Next Story